H. Lu

Genetic alterations and their therapeutic implications in epithelial ovarian cancer

Chien-hung Chen, K. Tan, Shu-Jen Chen, 2021, BMC Cancer.

Higher Decorin Levels in Bone Marrow Plasma Are Associated with Superior Treatment Response to Novel Agent-Based Induction in Patients with Newly Diagnosed Myeloma - A Retrospective Study

B. Ko, M. Yao, W. Tsay, 2015, PloS one.

Expression of cereblon protein assessed by immunohistochemicalstaining in myeloma cells is associated with superior response of thalidomide- and lenalidomide-based treatment, but not bortezomib-based treatment, in patients with multiple myeloma

Chung-Wu Lin, M. Yao, Yao-chang Chen, 2014, Annals of Hematology.

Ovarian cancer risk score predicts chemo-response and outcome in epithelial ovarian carcinoma patients

Y. Chiang, Yi-Jou Tai, W. Cheng, 2020, Journal of gynecologic oncology.

Correlation among DCE‐MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma

Bang-Bin Chen, T. Shih, Shang‐Yi Huang, 2012, American journal of hematology.